323 related articles for article (PubMed ID: 18398462)
21. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.
Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R
Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091
[TBL] [Abstract][Full Text] [Related]
22. CD133/CD140a-based isolation of distinct human multipotent neural progenitor cells and oligodendrocyte progenitor cells.
Wang J; O'Bara MA; Pol SU; Sim FJ
Stem Cells Dev; 2013 Aug; 22(15):2121-31. PubMed ID: 23488628
[TBL] [Abstract][Full Text] [Related]
23. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
[TBL] [Abstract][Full Text] [Related]
24. IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas.
Qiu B; Zhang D; Wang C; Tao J; Tie X; Qiao Y; Xu K; Wang Y; Wu A
Mol Biol Rep; 2011 Jun; 38(5):3585-91. PubMed ID: 21088899
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
26. CD133, CD15/SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-term cultured cancer stem cells from human malignant glio-neuronal tumors.
Patru C; Romao L; Varlet P; Coulombel L; Raponi E; Cadusseau J; Renault-Mihara F; Thirant C; Leonard N; Berhneim A; Mihalescu-Maingot M; Haiech J; Bièche I; Moura-Neto V; Daumas-Duport C; Junier MP; Chneiweiss H
BMC Cancer; 2010 Feb; 10():66. PubMed ID: 20181261
[TBL] [Abstract][Full Text] [Related]
27. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
[TBL] [Abstract][Full Text] [Related]
28. Targeting cancer stem cells through L1CAM suppresses glioma growth.
Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
[TBL] [Abstract][Full Text] [Related]
29. CD133 is a marker of bioenergetic stress in human glioma.
Griguer CE; Oliva CR; Gobin E; Marcorelles P; Benos DJ; Lancaster JR; Gillespie GY
PLoS One; 2008; 3(11):e3655. PubMed ID: 18985161
[TBL] [Abstract][Full Text] [Related]
30. Neural precursor cell susceptibility to human cytomegalovirus diverges along glial or neuronal differentiation pathways.
Cheeran MC; Hu S; Ni HT; Sheng W; Palmquist JM; Peterson PK; Lokensgard JR
J Neurosci Res; 2005 Dec; 82(6):839-50. PubMed ID: 16273540
[TBL] [Abstract][Full Text] [Related]
31. Expression and prognostic value of JAM-A in gliomas.
Rosager AM; Sørensen MD; Dahlrot RH; Boldt HB; Hansen S; Lathia JD; Kristensen BW
J Neurooncol; 2017 Oct; 135(1):107-117. PubMed ID: 28677106
[TBL] [Abstract][Full Text] [Related]
32. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
[TBL] [Abstract][Full Text] [Related]
33. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
34. Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells.
Niu CS; Li DX; Liu YH; Fu XM; Tang SF; Li J
Oncol Rep; 2011 Sep; 26(3):593-601. PubMed ID: 21573506
[TBL] [Abstract][Full Text] [Related]
35. Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomas.
Holmberg Olausson K; Maire CL; Haidar S; Ling J; Learner E; Nistér M; Ligon KL
PLoS One; 2014; 9(9):e106694. PubMed ID: 25184684
[TBL] [Abstract][Full Text] [Related]
36. Glial fibrillary acidic protein-expressing neural progenitors give rise to immature neurons via early intermediate progenitors expressing both glial fibrillary acidic protein and neuronal markers in the adult hippocampus.
Liu Y; Namba T; Liu J; Suzuki R; Shioda S; Seki T
Neuroscience; 2010 Mar; 166(1):241-51. PubMed ID: 20026190
[TBL] [Abstract][Full Text] [Related]
37. c-Myc is required for maintenance of glioma cancer stem cells.
Wang J; Wang H; Li Z; Wu Q; Lathia JD; McLendon RE; Hjelmeland AB; Rich JN
PLoS One; 2008; 3(11):e3769. PubMed ID: 19020659
[TBL] [Abstract][Full Text] [Related]
38. CD146 is highly expressed in glioma stem cells and acts as a cell cycle regulator.
Yawata T; Higashi Y; Kawanishi Y; Nakajo T; Fukui N; Fukuda H; Ueba T
J Neurooncol; 2019 Aug; 144(1):21-32. PubMed ID: 31147892
[TBL] [Abstract][Full Text] [Related]
39. Inflammation-related DNA damage and expression of CD133 and Oct3/4 in cholangiocarcinoma patients with poor prognosis.
Thanan R; Pairojkul C; Pinlaor S; Khuntikeo N; Wongkham C; Sripa B; Ma N; Vaeteewoottacharn K; Furukawa A; Kobayashi H; Hiraku Y; Oikawa S; Kawanishi S; Yongvanit P; Murata M
Free Radic Biol Med; 2013 Dec; 65():1464-1472. PubMed ID: 23917144
[TBL] [Abstract][Full Text] [Related]
40. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
